Sulfonyl fluorides for the treatment of alzheimer's disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/10 (2006.01) A61K 31/438 (2006.01) A61K 31/4409 (2006.01) A61K 31/661 (2006.01) A61K 47/44 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2264582

The present invention provides a pharmaceutical composition, comprising a sulfonyl fluoride and a pharmaceutically acceptable carrier. Also provided is a method of treating Alzheimer's disease in an individual in need of such treatment, comprising the step of administering to said individual a therapeutically effective dose of methanesulfonyl fluoride. Further provided is a method of enhancing cognitive performance in an individual in need of such treatment, comprising the step of administering to said individual a therapeutically effective dose of methanesulfonyl fluoride.

La présente invention se rapporte à une composition pharmaceutique contenant un fluorure de sulfonyle et un excipient pharmaceutiquement acceptable. L'invention concerne également un procédé de traitement de la maladie d'Alzheimer, chez un sujet justiciable d'un tel traitement, qui consiste à administrer audit sujet une dose thérapeutiquement efficace de fluorure de méthanesulfonyle. L'invention se rapporte en outre à un procédé permettant d'améliorer le rendement cognitif chez un sujet justiciable d'un tel traitement, qui consiste à administrer audit sujet une dose thérapeutiquement efficace de fluorure de méthanesulfonyle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sulfonyl fluorides for the treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfonyl fluorides for the treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonyl fluorides for the treatment of alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1457133

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.